SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0000947871-22-000719
Filing Date
2022-06-23
Accepted
2022-06-23 15:38:30
Documents
5
Group Members
FENNEC ACQUISITION INCSINO BIOPHARMACEUTICAL LTD

Document Format Files

Seq Description Document Type Size
1 TENDER OFFER STATEMENT ss1107826_sctoc.htm SC TO-C 21891
2 JOINT PRESS RELEASE BY SINO, PARENT AND THE COMPANY ss1107826_ex99a5a.htm EX-99.(A)(5)(A) 29166
3 PRESS RELEASE BY SINO ss1107826_ex99a5b.htm EX-99.(A)(5)(B) 16984
4 GRAPHIC image_001.jpg GRAPHIC 17285
5 GRAPHIC image_002.jpg GRAPHIC 11872
  Complete submission text file 0000947871-22-000719.txt   104795
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Subject) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-89626 | Film No.: 221035293
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 PRINCETON MEWS 167-169 LONDON ROAD KINGSTON UPON THAMES SURREY X0 KT2 6PT
Business Address 1 PRINCETON MEWS 167-169 LONDON ROAD KINGSTON UPON THAMES SURREY X0 KT2 6PT 44-7541691673
Invox Pharma Ltd (Filed by) CIK: 0001932556 (see all company filings)

IRS No.: 000000000
Type: SC TO-C